应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DNLI Denali Therapeutics Inc.
休市中 07-11 16:00:00 EDT
14.52
-0.83
-5.41%
盘后
14.52
+0.00
0.00%
19:47 EDT
最高
15.35
最低
14.38
成交量
169.18万
今开
15.05
昨收
15.35
日振幅
6.32%
总市值
21.09亿
流通市值
18.96亿
总股本
1.45亿
成交额
2,500万
换手率
1.30%
流通股本
1.31亿
市净率
1.88
ROE
-35.21%
每股收益
-2.67
52周最高
33.33
52周最低
10.57
市盈率
-5.44
股息
0.00
股息收益率
0.00
ROA
-22.58%
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至27.00美元。
金融界 · 05-19
B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至27.00美元。
异动解读 | Denali Therapeutics盘中大涨5.47%,分析师维持"优于大市"评级
异动解读 · 05-09
异动解读 | Denali Therapeutics盘中大涨5.47%,分析师维持"优于大市"评级
Denali Therapeutics Inc.盘中异动 早盘快速拉升5.02%
市场透视 · 05-09
Denali Therapeutics Inc.盘中异动 早盘快速拉升5.02%
Wedbush:维持Denali Therapeutics评级,由优于大市调整至优于大市评级, 目标价由32.00美元调整至30.00美元。
金融界 · 05-07
Wedbush:维持Denali Therapeutics评级,由优于大市调整至优于大市评级, 目标价由32.00美元调整至30.00美元。
Denali Therapeutics Inc.盘中异动 股价大跌5.00%报15.19美元
市场透视 · 05-06
Denali Therapeutics Inc.盘中异动 股价大跌5.00%报15.19美元
Denali Therapeutics Inc.盘中异动 大幅下跌5.11%
市场透视 · 05-01
Denali Therapeutics Inc.盘中异动 大幅下跌5.11%
Denali Therapeutics Inc.盘中异动 临近收盘大幅上涨5.04%报15.62美元
市场透视 · 04-24
Denali Therapeutics Inc.盘中异动 临近收盘大幅上涨5.04%报15.62美元
Denali Therapeutics Inc.盘中异动 快速上涨5.96%
市场透视 · 04-23
Denali Therapeutics Inc.盘中异动 快速上涨5.96%
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.02%报13.38美元
市场透视 · 04-21
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.02%报13.38美元
B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由30.00美元调整至28.00美元。
金融界 · 03-10
B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由30.00美元调整至28.00美元。
Denali Therapeutics Inc.盘中异动 早盘急速跳水5.03%
市场透视 · 03-10
Denali Therapeutics Inc.盘中异动 早盘急速跳水5.03%
Denali Therapeutics Inc.2024财年实现净利润-4.23亿美元,同比减少191.72%
市场透视 · 03-07
Denali Therapeutics Inc.2024财年实现净利润-4.23亿美元,同比减少191.72%
Denali Therapeutics Inc.盘中异动 早盘股价大跌5.55%报15.40美元
市场透视 · 03-06
Denali Therapeutics Inc.盘中异动 早盘股价大跌5.55%报15.40美元
B. Riley Securities:重申Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由38.00美元调整至35.00美元。
金融界 · 03-05
B. Riley Securities:重申Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由38.00美元调整至35.00美元。
奥本海默:维持Denali Therapeutics(DNLI.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至42.00美元。
金融界 · 03-03
奥本海默:维持Denali Therapeutics(DNLI.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至42.00美元。
Denali Therapeutics Inc.盘中异动 快速下跌5.07%
市场透视 · 03-03
Denali Therapeutics Inc.盘中异动 快速下跌5.07%
Denali Therapeutics(DNLI.US):2024年Q4财报实现营收0美元,前值为0美元,预期值为1258万美元;每股收益为-0.67美元,前值为-0.86美元,预期值为-0.91美元。
金融界 · 02-27
Denali Therapeutics(DNLI.US):2024年Q4财报实现营收0美元,前值为0美元,预期值为1258万美元;每股收益为-0.67美元,前值为-0.86美元,预期值为-0.91美元。
Denali Therapeutics 2024年第四季度GAAP每股收益$(0.67),优于$(0.76)的预期
财报速递 · 02-27
Denali Therapeutics 2024年第四季度GAAP每股收益$(0.67),优于$(0.76)的预期
Denali Therapeutics Inc.盘中异动 大幅下挫5.03%报19.63美元
市场透视 · 02-25
Denali Therapeutics Inc.盘中异动 大幅下挫5.03%报19.63美元
Denali Therapeutics(DNLI.US)获德银首次覆盖,给予买入评级, 目标价31.00美元。
金融界 · 02-11
Denali Therapeutics(DNLI.US)获德银首次覆盖,给予买入评级, 目标价31.00美元。
加载更多
公司概况
公司名称:
Denali Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
2017-12-08
主营业务:
Denali Therapeutics Inc.于2013年10月在特拉华州注册成立。他们的目标是发现和开发治疗方法来打败退化问题。神经退化代表了他们那个时代最重要的未得到满足的医疗需求之一,比如阿尔茨海默病,帕金森病疾病,肌萎缩性侧索硬化症或ALS,以及其他神经退化性疾病。这些疾病对患者和社会的负担是巨大的。他们相信现在正是他们利用强有力和雄心勃勃的努力来打败神经退化的正确时机。他们相信,他们可以在一个很少成功的领域取得了成就,因为他们拥有丰富的成功经验、热忱的科学家和药物开发者团队,他们专注的科学战略,以及他们专有的血脑屏障(BBB)平台输送技术。他们正在开发广泛的神经退行性疾病靶向治疗候选药物组合,并且最近开始了他们的第一个临床试验。他们于2015年5月开始运营。
发行价格:
18.00
{"stockData":{"symbol":"DNLI","market":"US","secType":"STK","nameCN":"Denali Therapeutics Inc.","latestPrice":14.52,"timestamp":1752264000000,"preClose":15.35,"halted":0,"volume":1691792,"hourTrading":{"tag":"盘后","latestPrice":14.52,"preClose":14.52,"latestTime":"19:47 EDT","volume":72748,"amount":1056300.88,"timestamp":1752277659807},"delay":0,"floatShares":130573596,"shares":145276299,"eps":-2.671368,"marketStatus":"休市中","change":-0.83,"latestTime":"07-11 16:00:00 EDT","open":15.05,"high":15.35,"low":14.38,"amount":24996286.01272,"amplitude":0.063192,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.671368,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1512709200000,"exchange":"NASDAQ","adjPreClose":15.35,"preHourTrading":{"tag":"盘前","latestPrice":15.13,"preClose":15.35,"latestTime":"09:29 EDT","volume":700,"amount":10816.7003,"timestamp":1752240599999},"postHourTrading":{"tag":"盘后","latestPrice":14.52,"preClose":14.52,"latestTime":"19:47 EDT","volume":72748,"amount":1056300.88,"timestamp":1752277659807},"volumeRatio":1.5438805932641457,"impliedVol":0.7583,"impliedVolPercentile":0.544},"requestUrl":"/m/hq/s/DNLI","defaultTab":"news","newsList":[{"id":"2536349526","title":"B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536349526","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536349526?lang=zh_cn&edition=full","pubTime":"2025-05-20 02:03","pubTimestamp":1747677794,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由28.00美元调整至27.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/20020350516640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"1135160005","title":"异动解读 | Denali Therapeutics盘中大涨5.47%,分析师维持\"优于大市\"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1135160005","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135160005?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:59","pubTimestamp":1746799153,"startTime":"0","endTime":"0","summary":"神经变性疾病治疗公司Denali Therapeutics今日盘中大涨5.47%,引起市场广泛关注。截至发稿,该股报价15.16美元/股,成交量3.1071万股,换手率0.02%,振幅5.06%。消息面上,知名投资银行Wedbush维持Denali Therapeutics的\"优于大市\"评级,但将目标价从32.00美元下调至30.00美元。Denali Therapeutics是一家专注于开发神经变性疾病疗法的生物技术公司。公司的主要研发项目包括LRRK2抑制剂,用于治疗帕金森病。在当前生物技术行业整体上涨0.43%的背景下,Denali Therapeutics的强劲表现凸显了投资者对其研发管线和市场前景的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Denali Therapeutics盘中大涨5.47%,分析师维持\"优于大市\"评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DNLI"],"gpt_icon":0},{"id":"2534480344","title":"Denali Therapeutics Inc.盘中异动 早盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534480344?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:37","pubTimestamp":1746797877,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时37分,Denali Therapeutics Inc.股票出现异动,股价急速拉升5.02%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.43%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。该信息摘要如下:Wedbush:维持Denali Therapeutics评级,由优于大市调整至优于大市评级, 目标价由32.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921375794f1d667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921375794f1d667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4548","BK4535","LENZ","DNLI","BK4139","BK4007"],"gpt_icon":0},{"id":"2533956968","title":"Wedbush:维持Denali Therapeutics评级,由优于大市调整至优于大市评级, 目标价由32.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533956968","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533956968?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:13","pubTimestamp":1746634396,"startTime":"0","endTime":"0","summary":"Wedbush:维持Denali Therapeutics(DNLI.US)评级,由优于大市调整至优于大市评级, 目标价由32.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050800164694ef7004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050800164694ef7004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNLI"],"gpt_icon":0},{"id":"2533522116","title":"Denali Therapeutics Inc.盘中异动 股价大跌5.00%报15.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533522116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533522116?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:08","pubTimestamp":1746544094,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时08分,Denali Therapeutics Inc.股票出现异动,股价大幅下挫5.00%。截至发稿,该股报15.19美元/股,成交量15.9864万股,换手率0.11%,振幅5.97%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为4.40%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506230814a4742aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506230814a4742aaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4548","BK4535","DNLI","LENZ"],"gpt_icon":0},{"id":"2532490008","title":"Denali Therapeutics Inc.盘中异动 大幅下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532490008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532490008?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:35","pubTimestamp":1746106523,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时35分,Denali Therapeutics Inc.股票出现波动,股价急速下挫5.11%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.68%。其相关个股中,Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Xtl生物制药涨幅较大,Processa Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为30.11%、19.72%、14.89%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Abpro Holdings, Inc,振幅分别为25.82%、14.25%、11.73%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213523a46ef2fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213523a46ef2fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4535","DNLI","BK4139","BK4548"],"gpt_icon":0},{"id":"2530624409","title":"Denali Therapeutics Inc.盘中异动 临近收盘大幅上涨5.04%报15.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530624409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530624409?lang=zh_cn&edition=full","pubTime":"2025-04-25 03:33","pubTimestamp":1745523204,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日03时33分,Denali Therapeutics Inc.股票出现异动,股价急速拉升5.04%。截至发稿,该股报15.62美元/股,成交量87.3951万股,换手率0.60%,振幅6.12%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.48%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425033324a465c77b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425033324a465c77b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4007","BK4535","DNLI","BK4139","LENZ"],"gpt_icon":0},{"id":"2529258682","title":"Denali Therapeutics Inc.盘中异动 快速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529258682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529258682?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415096,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Denali Therapeutics Inc.股票出现异动,股价急速拉升5.96%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Ensysce Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为2858.19%、17.87%、8.12%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Psyence Biomedical Ltd.,振幅分别为20.31%、16.54%、11.16%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213136aa2c7805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213136aa2c7805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNLI","LENZ","BK4535","BK4548","BK4007"],"gpt_icon":0},{"id":"2529383443","title":"Denali Therapeutics Inc.盘中异动 早盘股价大涨5.02%报13.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529383443?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:32","pubTimestamp":1745245943,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时32分,Denali Therapeutics Inc.股票出现异动,股价急速上涨5.02%。截至发稿,该股报13.38美元/股,成交量19.2573万股,换手率0.13%,振幅8.24%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223223a6c2809c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223223a6c2809c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNLI","LENZ","BK4535","BK4548","BK4007"],"gpt_icon":0},{"id":"2518082312","title":"B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由30.00美元调整至28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518082312","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518082312?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626170,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由30.00美元调整至28.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11010248641320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"2518385208","title":"Denali Therapeutics Inc.盘中异动 早盘急速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518385208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518385208?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:47","pubTimestamp":1741614463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时47分,Denali Therapeutics Inc.股票出现波动,股价快速下跌5.03%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2636.55%、601.31%、91.59%,振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、28.59%、25.35%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214743abf30282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214743abf30282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","LENZ","DNLI","BK4535"],"gpt_icon":0},{"id":"2517453968","title":"Denali Therapeutics Inc.2024财年实现净利润-4.23亿美元,同比减少191.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517453968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517453968?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363252,"startTime":"0","endTime":"0","summary":"3月8日,Denali Therapeutics Inc.公布财报,公告显示公司2024财年净利润为-4.23亿美元,同比减少191.72%;其中营业收入为0.00美元,每股基本收益为-2.57美元。机构评级:截至2025年3月8日,当前有16家机构对Denali Therapeutics Inc.目标价做出预测,其中目标均价为36.94美元,其中最低目标价为24.00美元,最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000228abed66a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000228abed66a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"2517162354","title":"Denali Therapeutics Inc.盘中异动 早盘股价大跌5.55%报15.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162354?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:33","pubTimestamp":1741271613,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时33分,Denali Therapeutics Inc.股票出现波动,股价急速跳水5.55%。截至发稿,该股报15.40美元/股,成交量3.5016万股,换手率0.02%,振幅2.67%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223333abeb784b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223333abeb784b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","DNLI","LENZ","BK4548","BK4139"],"gpt_icon":0},{"id":"2517294201","title":"B. Riley Securities:重申Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由38.00美元调整至35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294201","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294201?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:22","pubTimestamp":1741195338,"startTime":"0","endTime":"0","summary":"B. Riley Securities:重申Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由38.00美元调整至35.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06012248550715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"2516510756","title":"奥本海默:维持Denali Therapeutics(DNLI.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516510756","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516510756?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:00","pubTimestamp":1741024838,"startTime":"0","endTime":"0","summary":"奥本海默:维持Denali Therapeutics(DNLI.US)评级,由优于大市调整至优于大市评级, 目标价由50.00美元调整至42.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04020048498822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","DNLI"],"gpt_icon":0},{"id":"2516567096","title":"Denali Therapeutics Inc.盘中异动 快速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516567096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516567096?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:00","pubTimestamp":1741021227,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时00分,Denali Therapeutics Inc.股票出现异动,股价大幅跳水5.07%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为4043.54%、175.65%、144.19%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304010027989a3215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304010027989a3215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","LENZ","DNLI","BK4548"],"gpt_icon":0},{"id":"2514035432","title":"Denali Therapeutics(DNLI.US):2024年Q4财报实现营收0美元,前值为0美元,预期值为1258万美元;每股收益为-0.67美元,前值为-0.86美元,预期值为-0.91美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514035432","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514035432?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697718,"startTime":"0","endTime":"0","summary":"Denali Therapeutics(DNLI.US):2024年Q4财报实现营收0美元,前值为0美元,预期值为1258万美元;每股收益为-0.67美元,前值为-0.86美元,预期值为-0.91美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"1164845017","title":"Denali Therapeutics 2024年第四季度GAAP每股收益$(0.67),优于$(0.76)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1164845017","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164845017?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:38","pubTimestamp":1740692304,"startTime":"0","endTime":"0","summary":"Denali Therapeutics公布的季度每股亏损为$,比分析师一致预期的$高出11.84%。与去年同期的每股亏损$相比,这实现了22.09%的增长。以上内容来自Benzinga Earnings专栏,原文如下:Denali $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.84 percent. This is a 22.09 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"2514197800","title":"Denali Therapeutics Inc.盘中异动 大幅下挫5.03%报19.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514197800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514197800?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:13","pubTimestamp":1740500033,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时13分,Denali Therapeutics Inc.股票出现异动,股价快速跳水5.03%。截至发稿,该股报19.63美元/股,成交量19.9454万股,换手率0.14%,振幅5.61%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.53%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001354a2539e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001354a2539e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNLI","LENZ","BK4535","BK4548","BK4139"],"gpt_icon":0},{"id":"2510358965","title":"Denali Therapeutics(DNLI.US)获德银首次覆盖,给予买入评级, 目标价31.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510358965","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510358965?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:02","pubTimestamp":1739296955,"startTime":"0","endTime":"0","summary":"Denali Therapeutics(DNLI.US)获德银首次覆盖,给予买入评级, 目标价31.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12020248092616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DNLI","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.denalitherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0441},{"period":"3month","weight":0.1433},{"period":"6month","weight":-0.2398},{"period":"1year","weight":-0.3712},{"period":"ytd","weight":-0.2875}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Denali Therapeutics Inc.于2013年10月在特拉华州注册成立。他们的目标是发现和开发治疗方法来打败退化问题。神经退化代表了他们那个时代最重要的未得到满足的医疗需求之一,比如阿尔茨海默病,帕金森病疾病,肌萎缩性侧索硬化症或ALS,以及其他神经退化性疾病。这些疾病对患者和社会的负担是巨大的。他们相信现在正是他们利用强有力和雄心勃勃的努力来打败神经退化的正确时机。他们相信,他们可以在一个很少成功的领域取得了成就,因为他们拥有丰富的成功经验、热忱的科学家和药物开发者团队,他们专注的科学战略,以及他们专有的血脑屏障(BBB)平台输送技术。他们正在开发广泛的神经退行性疾病靶向治疗候选药物组合,并且最近开始了他们的第一个临床试验。他们于2015年5月开始运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037766},{"month":2,"riseRate":0.375,"avgChangeRate":-0.022228},{"month":3,"riseRate":0.25,"avgChangeRate":-0.087093},{"month":4,"riseRate":0.625,"avgChangeRate":0.0118},{"month":5,"riseRate":0.75,"avgChangeRate":0.047446},{"month":6,"riseRate":0.625,"avgChangeRate":0.059984},{"month":7,"riseRate":0.5,"avgChangeRate":-0.040013},{"month":8,"riseRate":0.571429,"avgChangeRate":0.06218},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032087},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.060112},{"month":11,"riseRate":0.571429,"avgChangeRate":0.12875},{"month":12,"riseRate":0.428571,"avgChangeRate":0.034328}],"exchange":"NASDAQ","name":"Denali Therapeutics Inc.","nameEN":"Denali Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Denali Therapeutics Inc.(DNLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Denali Therapeutics Inc.(DNLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Denali Therapeutics Inc.,DNLI,Denali Therapeutics Inc.股票,Denali Therapeutics Inc.股票老虎,Denali Therapeutics Inc.股票老虎国际,Denali Therapeutics Inc.行情,Denali Therapeutics Inc.股票行情,Denali Therapeutics Inc.股价,Denali Therapeutics Inc.股市,Denali Therapeutics Inc.股票价格,Denali Therapeutics Inc.股票交易,Denali Therapeutics Inc.股票购买,Denali Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Denali Therapeutics Inc.(DNLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Denali Therapeutics Inc.(DNLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}